Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Biostatistics and Clinical Data Management / Allison M. Deal, M.S.

Allison M. Deal, M.S.

Allison Deal

Biostatistician

Biostatistics and Clinical Data Management Core Facility

919-966-1387

Allison_Deal@med.unc.edu

 

Education

M.S. Biostatistics, University of North Carolina, 2007
B.S. Statistics, Pennsylvania State University, 2005
B.S. Mathematics, Pennsylvania State University, 2005

Publications

Ollila DW, J Ashburn, KD Amos, JJ Yeh, JS Frank, AM Deal, P Long, ND Thomas, MO Meyers. “Metastatic Melanoma Cells in the Sentinel Node Cannot be Ignored.” Journal of American College of Surgeons. (2009)Volume 208 (5).

Patel MR, PC Bryson, CG Shores, CF Hart LB Thorne, AM Deal, AM Zanation.  “Trefoil Factor 3 (TFF-3) Immunohistochemistry Characterization of Follicular Thyroid Lesions from Tissue Microarray.” Archives of Otolaryngology Head & Neck Surgery. (2009) 135(6):590-596.

Meyers MO, JJ Yeh, J Frank, P Long, AM Deal, KD Amos, DW Ollila. “Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging.” Annals of Surgical Oncology. (2009) 16:941–947.

Patel M, Deal AM, Shockley WW. “Oral and Plunging Ranulas: What is the most effective treatment?” The Laryngoscope. (2009) 119:1501-1509.

Blatt J, AM Deal, G Mesibov. “Autism in Children and Adolescents with Cancer: A Pilot Study.” Pediatric Blood & Cancer, (2010) 54:144-147.

Puvvada, SD, WK Funkhouser, K Greene, AM Deal, H Chu, AS Baldwin, JE Tepper, BH O'Neil. “Prognostic implication of NF-κB and BCL3 activation in metastatic colorectal cancer.” Oncology, (2010) 78(3-4): 181-188.

O’Neil, BH, WK Funkhouser, BF Calvo, MO Meyers, HJ Kim, RM Goldberg, SA Bernard, L Caskey, AM Deal, F Wright, AS Baldwin, JE Tepper. “NF-κB is activated by radiotherapy and is prognostic for overall survival in patients with rectal cancer treated with preoperative fluorouracil-based chemoradiation.” International Journal of Radiation Oncology- Biology-Physics, (2010) In Press.

Seaman WT, E Andrews, M Couch, EM Kojic, S Cu-Uvin, J Palefsky, AM Deal, J Webster-Cyriaque. “Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.” Virology Journal, (2010) 7:194.

Watson RG, F Muhale, LB Thorne, J Yu, BH O’Neil, JM Hoskins, MO Meyers, AM Deal, JG Ibrahim, ML Hudson, CM Walko, HL McLeod, JT Auman, “Amplification of Thymidylate Synthetase in Metastatic Colorectal Cancer Patients Pretreated with 5-Fluorouracil-based Chemotherapy.” European Journal of Cancer, (2010)46(18): 3358-3364.

Meyers, MO, JJ Yeh, AM Deal, FL Byerly, JT Woosley, J Frank, PK Long, KD Amos, DW Ollila, “Age and Breslow Depth Are Associated With a Positive Sentinel Lymph Node in Patients with Cutaneous Melanocytic Tumors of Uncertain Malignant Potential.” Journal of the American College of Surgeons, (2010)211(6): 744-748.

Anders, CK, AM Deal, C Khorram, H Meng, E Burrows, C Livasy, K Fritchie, MG Ewend, CM Perou, LA Carey. “The Prognostic Contribution of Clinical Breast Cancer Subtype, Age and Race among Patients with Breast Cancer Brain Metastases.” Cancer, (2010)In Press.

Cates, JR, A Shafer, SJ Diehl, AM Deal. “Evaluating a County-Sponsored Social Marketing Campaign to Increase Mothers’ Initiation of HPV Vaccine for their Pre-teen Daughters in a Primarily Rural Area.” Social Marketing Quarterly, (2010) In Press.

Getting Started

For new requests or questions concerning the Biostatistics (BIOS) Core, please email us at:

If you are unsure how much, or how little, statistical or research design input you might need, a good first step would be to meet informally with a LCCC statistician at our Walk-In Clinic. These clinics are on Tuesdays and Thursdays from 12 to 1 pm. Talking with a statistician at one of these clinics can be a good starting point, and a good way to get introduced to the BIOS Core and our Core services that might be of interest to you.

The LCCC BIOS Core looks to match statisticians with researchers and their projects based on expertise, interest, and availability. Besides LCCC Core Statisticians, the Core also has access to other UNC Statisticians, particularly School of Public Health Statisticians that may be available and interested in collaborating on a particular project.

The BIOS Core is a ‘no-charge’ facility. However, advice on including one of our statisticians on a grant for a certain ‘percent effort’ (i.e. how much and when this might called for and appropriate) is readily available.

Software

Researchers, and particularly other statisticians and data analysts, may be interested in software made available by LCCC statisticians. Please click on the ‘software’ link next to a statistician's name to review what is available and to gain access. Please feel free to return to these pages for possible software updates and additions.

Walk-In Clinic Hours

Now available on Tuesdays and Thursdays

12 noon to 1 p.m.

in the atrium on the first floor of the Lineberger building

What is a walk-in clinic? Learn more!

Welcome Dr. Anna Snavely

Born in Greensboro, Anna earned her undergraduate degree in mathematics with a concentration in statistics from Wake Forest University.  She completed her PhD in Biostatistics at Harvard University in 2012. Her dissertation work was motivated by cancer clinical trials and involved methods for analyzing clustered survival and multiple outcomes data.

While at Harvard, Anna was involved in many collaborative projects at Dana-Farber Cancer Institute. In particular, she worked with investigators at the Center for Community-Based Research, the Head and Neck Cancer Program, and the Lance Armstrong Foundation Adult Survivorship Program.

We are very pleased to have Anna with us! Please join us in welcoming her to our Cancer Center.